Follow The Filings

CME CME Group

Financials, filed as CME GROUP INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 6 managers in 2026 Q2, sold by 2

  • 11 Owners
  • #90
  • Max 2.5%
  • Master 0.08%
  • $1.4B
  • 3 new 3 add 1 reduce 1 small

In 2026 Q2, 3 managers opened positions, 3 added, and 1 trimmed.

Who owns this now

Largest portfolio weights among holders, up to 2.5% (Seth Klarman, Baupost Group). Not free-float ownership.

  1. Seth Klarman New 2.5%
  2. William Von Mueffling Reduce 2.1%
  3. Lewis Sanders Add 1.1%
  4. Arnold Van Den Berg Add 1.0%
  5. Murray Stahl Add 0.71%
  6. Mairs & Power New 0.40%

Who owns CME

Sorted by value, long equity only, as of 2026 Q2.

History
Lewis Sanders, Sanders Capital 1.1% Add +21.8% 5,067,740 $1.1B History
Seth Klarman, Baupost Group 2.5% New 2.5% 619,000 $137M History
Murray Stahl, Horizon Kinetics Asset Management 0.71% Add +5.0% 283,774 $63M History
Mairs & Power 0.40% New 0.40% 195,585 $43M History
Andreas Halvorsen, Viking Global Investors 0.10% New 0.10% 152,980 $34M History
William Von Mueffling, Cantillon Capital Management 2.1%, was 2.7% Reduce −95.4% 63,835 $14M History
Ron Baron, Bamco Inc. (Baron Capital) 0.02%, was 0.05% Small trim −2.8% 50,234 $11M History
Thomas Gayner, Markel Group 0.08% Hold 49,750 $11M History
George Soros, Soros Fund Management 0.08% Hold 30,028 $6.6M History
Arnold Van Den Berg, Van Den Berg Management I 1.0% Add +19.4% 22,089 $4.9M History
Lindsell Train 0.06% Hold 6,900 $1.5M History

11 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CME's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CME insider trades
  • $667K bought by 1 insider
  • $30.6M sold by 10 insiders outside a trading plan
  • $1M sold by 1 insider under 10b5-1 plans
  1. Sunil Cutinho Chief Information Officer
    Sale
    $1.5M 5,000 shares at $298.70 20% of stake
    Traded Oct 27 Filed Oct 27
    ↗
  2. Martin J Gepsman Director
    Sale
    $121K 400 shares at $302.50 1.6% of stake
    Traded Oct 22 Filed Oct 22
    ↗
  3. William R Shepard Director
    Buy
    $79K 293 shares at $268.76 +0.1% to stake
    Traded Sep 25 Filed Sep 28
    ↗
  4. Elizabeth A Cook Director
    Sale
    $140K 500 shares at $280.11 2.7% of stake
    Traded Sep 14 Filed Sep 14
    ↗
  5. Terrence A Duffy CEO
    Sale
    $4.1M 15,000 shares at $274.44 27% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  6. William R Shepard Director
    Buy
    $78K 339 shares at $230.57
    Traded Jun 25 Filed Jun 29
    ↗
  7. Hilda Harris Piell Sr MD & Chief HR Officer
    Sale
    $1.8M 5,753 shares at $304.63 17% of stake
    Traded May 18 Filed May 19
    ↗
  8. Terrence A Duffy CEO
    Sale
    $10.4M 35,000 shares at $298.51 39% of stake
    Traded May 15 Filed May 18
    ↗
  9. William R Shepard Director
    Buy
    $437K 1,470 shares at $297.38
    Traded Mar 26 Filed Mar 30
    ↗
  10. Jonathan L Marcus Sr MD General Counsel
    Planned sale
    $1M 3,291 shares at $313.37 31% of stake
    Traded Mar 17 Filed Mar 23
    ↗
  11. Ken Vroman Chief Transformation Officer
    Sale
    $1.6M 5,160 shares at $309.00 26% of stake
    Traded Mar 12 Filed Mar 12
    ↗
  12. Elizabeth A Cook Director
    Sale
    $320K 1,000 shares at $320.00 5.3% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  13. Bryan T Durkin Director
    Sale
    $1.3M 4,200 shares at $309.65 8.9% of stake
    Traded Feb 23 Filed Feb 23
    ↗
  14. Martin J Gepsman Director
    Sale
    $92K 300 shares at $305.90 1.2% of stake
    Traded Feb 20 Filed Feb 20
    ↗
  15. Dennis Suskind Director
    Sale
    $224K 748 shares at $300.00 22% of stake
    Traded Feb 6 Filed Feb 9
    ↗

Also filed in the last 12 months, not counted as buying or selling: 55 share withholdings for taxes, 45 stock grants, 8 other transactions, and 2 gifts.

Congress

11 members of Congress traded CME in the last three years: 10 buys and 10 sales. 10 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Jun 16 filed Jul 2
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jan 9 filed Feb 13
  4. Julie Johnson D-TX-32Joint Sell $1K–$15K Dec 18, 2025 filed Jan 15
  5. Julie Johnson D-TX-32Joint Partial sale $1K–$15K Nov 13, 2025 filed Dec 11, 2025
  6. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.03 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $5.58B $6.13B $6.52B
Net income $3.23B $3.53B $4.07B
Net margin * 57.8% 57.5% 62.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $94.89B $103.03B $165.36B
Total non-current assets * $34.82B $34.41B $33.06B
Total assets $129.71B $137.45B $198.42B
Total current liabilities $93.42B $102.31B $160.3B
Total non-current liabilities * $9.55B $8.65B $9.4B
Total equity $26.74B $26.49B $28.73B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $3.45B $3.69B $4.28B
Cash from investing $0.021B -$0.083B $1.5B
Cash from financing -$48.34B $5.08B $56.51B
Net change in cash -$44.86B $8.68B $62.29B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.